Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Warren E. Buffett, 2008
Allayannis, George (Yiorgos)Caso DARDEN-F-1550-EFinanzasIn January 2008, in the midst of the subprime-mortgage crisis, Warren Buffett is looking for good investment opportunities for his almost $50 billion in cash. As usual, he has been patient and careful in identifying the right opportunities; however, the amount of cash in his company has grown considerably, and with so much cash sitting idle, returns could suffer. This case can be used to pursue several objectives: (1) to showcase Warren Buffett’s...Desde 8,20 €
-
Warren E. Buffett, 2008 - Teaching Note
Allayannis, George (Yiorgos)Nota del Instructor DARDEN-F-1550TN-EFinanzasTeaching note for product F-1550Desde 0,00 €
-
New Leaders of Financial Giants: The Cases of Vikram Pandit (Citi) and John Thain (Merrill Lynch)
Allayannis, George (Yiorgos)Caso DARDEN-F-1551-EFinanzasIn January 2008, Citi and Merrill Lynch are trying to steer their ships back to calm waters. The new CEOs, Vikram Pandit (Citi) and John Thain (Merrill), have been at the helm of their companies for less than three months. This case focuses on their steps to counteract the massive losses resulting from their firms' investments in subprime-mortgage structures. What actions have these leaders taken thus far and what actions should they consider goi...Desde 8,20 €
-
Deutsche Bank and the Road to Basel III
Allayannis, George (Yiorgos); Wicks, Andrew C.; Yemen, Gerry; Dougherty, MatthewCaso DARDEN-F-1695-EFinanzasThis public-sourced case was named the best finance case of 2013 in the 24th annual awards and competition sponsored by The Case Centre. It was designed for and works well in the latter portion of a GEMBA Financial Management and Policies course and in the early stage of a second-year MBA elective Financial Institutions and Markets course. The case is set in mid-2012 as the new co-CEOs of Deutsche Bank are about to speak in an analyst call. Stude...Desde 8,20 €
-
Fintech, Payments Innovation, and the Acquisition of Worldpay
Allayannis, George (Yiorgos); Yemen, Gerry; Lane, DavidCaso DARDEN-F-1829-EFinanzasThis case uses the Vantiv, a US credit-card-processing company, acquisition of Worldpay, Britain’s largest payments processor, to discuss broader themes in the payment space. Payments are a crucial function of financial institutions because of their sheer volume and revenue potential. Fintech has enabled more ways for financial institutions and consumers to make payments and has the potential for significant disruption. The material in the case a...Desde 8,20 €
-
KTM - Venture Capitalist Exit
Stephen Sapp; Charlene Zietsma; Iris Fischlmayr; Rob WongCaso IVEY-9B07N003-EDirección estratégica, Finanzas, Iniciativa emprendedoraKTM is a small motorcycle manufacturing company located in Austria. As a result of difficult economic conditions in 1999, KTM went private with the help of the venture capital firm BC European Capital (BC). Following a couple of years of strong growth, BC is looking to liquidate its position and move on. KTM is faced with the decision of determining the best means to repurchase BC's equity position in the firm and leave the firm with enough finan...Desde 8,20 €
-
Business Succession and the Asher Estate - Teaching Note
Stephen Sapp; Alykhan AlidinaNota del Instructor IVEY-8B20N011-EFinanzasTeaching note for product 9B20N011.Desde 0,00 €
-
Magna International and Dual Share Unification - Teaching Note
W. Glenn Rowe; Stephen Sapp; Nadine de Gannes; Abbas KhambatiNota del Instructor IVEY-8B20M209-EDirección estratégicaTeaching note for product 9B20M209.Desde 0,00 €
-
CanniMed Therapeutics: Acquiror or Target
Stephen Sapp; Shane FreedmanCaso IVEY-9B20N008-EFinanzas, Iniciativa emprendedoraOn November 14, 2017, Aurora Cannabis Inc. (Aurora) made a proposal to CanniMed Therapeutics Inc. (CanniMed) to acquire all of CanniMed’s issued and outstanding common shares in a share exchange that valued CanniMed’s common shares at a premium of almostDesde 8,20 €
-
CS Publishing Inc.: Foreign Exchange Risk Management - Teaching Note
Stephen SappNota del Instructor IVEY-8B19N024-EFinanzasTeaching note for product 9B19N024.Desde 0,00 €